Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prolactinoma in pregnancy
Mark E. Molitch
*
*
Corresponding author for this work
Medicine, Endocrinology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
93
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prolactinoma in pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Macroadenoma
100%
Prolactinoma
100%
Tumor Growth
66%
Dopamine Agonist
66%
Bromocriptine
66%
Ablative Therapy
66%
Cabergoline
66%
Infertility
33%
Clinically Significant
33%
Tumor
33%
Preterm Delivery
33%
Spontaneous Preterm Birth (sPTB)
33%
Normal Population
33%
Ovulation
33%
Congenital Malformations
33%
Debulking
33%
Transsphenoidal
33%
Visual Field
33%
Microadenoma
33%
Multiple Births
33%
Therapeutic Ratio
33%
Preferred Mode
33%
Medicine and Dentistry
Prolactinoma
100%
Macroadenoma
100%
Dopamine Agonist
66%
Tumor Progression
66%
Ablation Therapy
66%
Bromocriptine
66%
Cabergoline
66%
Pregnancy
33%
Neoplasm
33%
Congenital Malformation
33%
Premature Labor
33%
Debulking
33%
Visual Field
33%
Spontaneous Abortion
33%
Ovulation
33%
Microadenoma
33%
Therapeutic Window
33%